NCT02328677 ColoCare Study - Colorectal Cancer Cohort
| NCT ID | NCT02328677 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2007-03 |
| Primary Completion | 2030-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2007-03 with a primary completion date of 2030-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).
Eligibility Criteria
Inclusion Criteria: 1. Age 18-89 years; for patients recruited after 09/01/2021 the age range is 18-69 years. Recruitment of patients 70 years and older was maintained for specific sub-studies and re-initiated for specific R01 grant funding in \~06/2024 2. Men and women 3. Newly-diagnosed colon or rectal cancer (stages I-IV); CRC in treatment (FHCRC and HCI) 4. English (FHCRC, Moffitt, HCI, Cedars-Sinai, WashU St. Louis) or German (University Hospital Heidelberg)-speaking; 5. mentally/physically able to consent and participate. Exclusion Criteria: * if one of the above in not fulfilled * insufficient language or consent capacity
Contact & Investigator
Cornelia M Ulrich, MS, PhD
PRINCIPAL INVESTIGATOR
Huntsman Cancer Institute
Frequently Asked Questions
Who can join the NCT02328677 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02328677 currently recruiting?
Yes, NCT02328677 is actively recruiting participants. Contact the research team at neli.ulrich@hci.utah.edu for enrollment information.
Where is the NCT02328677 trial being conducted?
This trial is being conducted at Los Angeles, United States, Tampa, United States, St Louis, United States, Knoxville, United States and 3 additional locations.
Who is sponsoring the NCT02328677 clinical trial?
NCT02328677 is sponsored by University of Utah. The principal investigator is Cornelia M Ulrich, MS, PhD at Huntsman Cancer Institute. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.